News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26, with sequential growth in core segment BRAINBiocatalysts and a new European patent for genome editing. Full year guidance confirmed -
-
-
-